Patents by Inventor Rick De Waard

Rick De Waard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dermatologic use of milk proteins
    Patent number: 8147875
    Abstract: The invention provides a method for the treatment of acne comprising orally administering to a person suffering from acne an effective amount of a whey protein fraction containing lactoferrin, and preferably containing further specific whey proteins. The lactoferrin is preferably native bovine lactoferrin and the whey protein fraction is administered at a level of between 10 mg and 2 g lactoferrin per patient per day.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: April 3, 2012
    Assignee: Campina Nederland Holding B.V.
    Inventors: Rick De Waard, Angela Loriann Walter
  • Antiviral peptides
    Publication number: 20090074893
    Abstract: The invention provides a method for the prevention or treatment of virus infections comprising administering, to a human or animal individual susceptible to or suffering from a virus infection, an effective amount of one or more casein phosphopeptides (CPP). Also provided is a composition containing such casein peptides and further agents such as vitamin C and/or nutritional components for use in treating or preventing virus infections.
    Type: Application
    Filed: April 28, 2006
    Publication date: March 19, 2009
    Applicant: CAMPINA NEDERLAND HOLDING B.V.
    Inventors: Rick de Waard, Yves Pouliot, Christina Juneau, Leon Franciscus Mallee
  • Dermatologic Use Of Milk Proteins
    Publication number: 20080193551
    Abstract: The invention provides a method for the treatment of acne comprising orally administering to a person suffering from acne an effective amount of a whey protein fraction containing lactoferrin, and preferably containing further specific whey proteins. The lactoferrin is preferably native bovine lactoferrin and the whey protein fraction is administered at a level of between 10 mg and 2 g lactoferrin per patient per day.
    Type: Application
    Filed: March 14, 2006
    Publication date: August 14, 2008
    Inventors: Rick De Waard, Angela Loriann Walter